Rasmussen, B B <br/><br/>
Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?  [electronic resource] 

 -  Therapeutic drug monitoring  Apr 2000 
 - 143-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0163-4356 
<br/><br/><label>Standard No.: </label>10.1097/00007691-200004000-00001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biotransformation<br/>Cytochrome P-450 Enzyme System--physiology<br/>Drug Interactions<br/>Drug Monitoring<br/>Humans<br/>Selective Serotonin Reuptake Inhibitors--blood